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ABSTRACT. Background: Parenteral nutrition (PN) is
known to induce villus atrophy, epithelial cell (EC) apoptosis,
and increase mucosal permeability. The study hypothesized
that increasing amounts of energy delivery to mice would
result in the best outcome, with the least effects on the
mucosa. Methods: Mice were randomized to enteral controls
(saline infusion with ad libitum enteral food) or to 1 of 3 PN
groups (with no enteral nutrition): full (100% of daily average
energy intake for the mouse), reduced (75% of energy intake)
or very low (50% of energy intake). Mice received PN for 7
days. Mucosal morphology, EC apoptosis, and bacterial
translocation were assessed. Results: Villus height decreased
significantly with decreasing levels of caloric intake and was
significantly lower in all PN groups compared with controls.
Body weight loss was significantly greater in PN groups vs
controls and was greatest in mice with the lowest caloric
delivery. A consistent trend toward a higher EC apoptotic
index with decreasing caloric intake was observed, and apo-
ptosis in all PN groups exceeded controls (2-fold). All PN
groups demonstrated greater bacterial translocation than
controls. Conclusions: PN induces intestinal EC apoptosis and
villus and crypt atrophy, even at 100% of predicted energy
needs, and such changes increased with greater reduction of
energy intake. This study supports a concept that lack of
enteral nutrition, rather than absolute caloric levels, is
responsible for many of the adverse effects of PN. The study
also allows the investigators to better optimize a mouse
model of PN delivery. ( Journal of Parenteral and Enteral Nutri-
tion 30:474–479, 2006)
Parenteral nutrition (PN) is known to induce signif-
icant changes in mucosal structure and function. These
changes include villus atrophy, epithelial cell (EC) apo-
ptosis, and altered mucosal permeability. PN adminis-
tration is associated not only with morphologic changes
in the intestine but also with bacterial translocation
and a loss of mucosal barrier function.1–3 The mecha-
nisms of PN-associated loss of epithelial integrity and
morphologic changes have been studied extensively
using a mouse model.1–6 The use of a mouse model can
offer great insights into these PN-associated effects on
the gastrointestinal tract. Recent work by our group
has helped to identify mechanisms that contribute to
the occurrence of bacterial translocation and villus
atrophy.1–3,6 Unlike other animal models, the use of
mice is relatively inexpensive, allows for an extensive
study of the alterations in their immune system, and
can be managed in a small laboratory setting. Delivery
of PN to mice, however, is a challenge and has been
associated with a moderate mortality.7 To ad-
dress this problem, this study was designed to deter-
mine the amount of energy delivery via PN using a
mouse model, whereby the closest approximation to
energy needs is met and with the fewest number of
complications. We also sought to determine whether
different levels of energy delivery, administered as PN,
correlated with PN-associated intestinal changes. We
further attempted to determine the most optimal
amount of energy delivery while optimizing mouse sur-
vival and morbidity. We hypothesized that higher
energy delivery via PN would result in fewer aberra-
tions in intestinal morphology and improved survival.
MATERIALS AND METHODS
Animals
C57BL/6J male specific-pathogen-free mice (8 weeks
old) were obtained from Jackson Laboratory (Bar Har-
bor, ME) and were maintained under temperature-,
humidity-, and light-controlled conditions. Mice were
initially fed ad libitum with standard mouse chow and
water and allowed to acclimate. During the adminis-
tration of IV solutions, mice were housed in metabolic
cages to prevent coprophagia. The studies reported
here conformed to the guidelines for the care and use of
laboratory animals established by the University Com-
mittee on Use and Care of Animals at the University of
Michigan, and protocols were approved by that com-
mittee (No. 7703).
Operative Procedures and Study Groups
Mice were anesthetized with sodium pentobarbital
(50 mg/kg/body weight, intraperitoneal). All surgical
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procedures were performed under magnification in a
sterile fashion. The left jugular vein was exposed and
cannulated with a silicone rubber catheter (0.012-inch
ID, 0.025-inch OD; Dow Corning, Midland, MI). The
distal end of the catheter was tunneled subcutaneously
and exited between the scapulae. The catheter was
attached to a swivel spring, which allowed the mice
freedom of movement in their individual cages (Meta-
mount System, Instech Corp, Plymouth Meeting, MA).
Catheterized mice were immediately connected to an
infusion pump (AIM pain provider pump, generously
donated by Abbott Laboratories, Abbott Park, IL) and
saline (dextrose 5% in 0.45 NS with 20 mEq KCl/L) was
infused at an initial rate of 4.8 mL/d. After 24 hours,
the animals were randomized to control or PN groups.
Of note, the AIM pain provider pump is one of the most
accurate available to date. Nevertheless, the delivery is
cyclical and not continuous. Thus, as infusion rates
increased, we found that some mice developed extrav-
asation of IV PN. These mice were not included in the
study results.
Average daily caloric intake was measured for mice
provided enteral chow ad libitum (assessed via daily
measurements of feed consumption with mice in met-
abolic chambers, data not shown) and was found to be
470 kcal/kg/d for 8-week-old mice of 22 g body weight,
which closely agrees with known estimates of normal
caloric consumption for mice,6,7 as well as estimates
provided by the Purina Mills Veterinary Service8
(Table I).
Study Groups
Mice were then provided PN at 100%, 75%, or 50% of
normal mouse energy intake (470 kcal/kg/d, Full
group, n  5; vs 350 kcal/kg/d, Reduced group, n  6;
and 235 kcal/kg/d, Very Low group, n  7; respectively,
Table I) and were not permitted any enteral nutrition
but were allowed ad libitum water. PN was formulated
by a clinical PN supplier (HomeMed of the University
of Michigan Health System, Ann Arbor, MI) and con-
tained a balanced mixture of amino acids, lipids, and
dextrose, in addition to electrolytes and vitamins
(Table II). All mice receiving PN were provided drink-
ing water ad libitum but no enteral feedings during the
7 days receiving PN. The control group (n  6) received
IV physiologic saline at 0.2 mL/h, in addition to stan-
dard mouse chow and water ad libitum. All animals
were euthanized with CO2 at 7 days. Body weight was
recorded both before the initiation of the study and
after the mice were euthanized.
Bacteriological Cultures
Methods used were similar to those previously
described.9,10 After killing, and using sterile technique,
samples of tissue from mesenteric lymph nodes, liver,
and spleen were excised. Each tissue sample was incu-
bated in thioglycolate broth for 24 h at 37°C and then
subcultured onto both MacConkey media for isolation
of Gram-negative bacteria, and colistin nalidixic acid
media (Becton Dickinson, Cockeysville, MD) for isola-
tion of Gram-positive bacteria in an aerobic environ-
ment. After an additional 24-hour incubation period,
growth on each plate was recorded as either positive or
negative. Positive cultures were considered indicative
of bacterial translocation.9,10
Intestinal Morphology
Intestinal specimens were immediately fixed in 10%
neutral buffered formalin after killing. Specimens
were paraffin embedded and cut into 5-m-thick tissue
slices, parallel with the longitudinal axis of the bowel.
Tissue slices were mounted and stained with hematox-
ylin and eosin for assessment of villus length and crypt
TABLE I










Full PN, n  5 471 19.2 7.7 100 0.4
Reduced PN, n  6 353 14.4 5.8 75 0.3
Very Low PN, n  7 236 9.6 3.9 50 0.2
Control (enteral), n  6* 486 30 6.6 100 0.2 (saline)
Mean caloric delivery was based on the initial average body weight (22 g). There was no difference between groups in initial body weight.
PN groups did not receive any enteral intake.
*Estimate from Purina Mills Chow Inc., assuming 4-g consumption of food per day, a net metabolizable amount of nutrients (excludes
nondigestible fibers), and a mouse weighing 22 g.
TABLE II
Parenteral nutrition (PN) formulation
Amount per
50 mL formulated PN
Volume (mL) of
component in 50 mL
kcal/mL of
individual component
Aminosyn II 10% 2 g protein equivalent 20 0.40
Dextrose 70% 12.5 g dextrose 18 2.38
Liposyn II 20% 1 g fat 5 2.0
Electrolytes 6.07 0
Water 0.93 0
Total volume of final PN (mL)* 50 1.227kcal/mL
*All PN solutions were supplemented with multivitamins and a complete trace-elements package, as previously described.22
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depth. Five different fields of each specimen were
observed, and digital images were recorded with com-
puter-aided video microscopy (Eclipse TS100, Nikon
Inc, NY). Villus length and crypt depth for each spec-
imen were measured and analyzed using commercially
available quantitative digital image analysis software
(Media Cybernetics Inc, MD). Each measurement con-
sisted of the mean of 5 different fields. At least 20 villi
were counted and averaged for each sample, and only
villi with an intact central lymphatic channel were
considered.
Assessment of Apoptosis
Tissue sections were stained with terminal-deoxynu-
cleotidyl transferase nick-end labeling (TUNEL) for
quantification of apoptosis in situ. The ApopTag InSitu
Apoptosis Detection Kit (Serologic Corporation, Nor-
cross, GA) was used according to the manufacturer’s
instructions. Apoptosis was defined by both the finding
of apoptotic bodies with positive TUNEL staining as
well as by morphologic criteria (pyknotic nuclei, con-
densed chromatin, and nuclear fragmentation).11–13
Apoptosis was assessed by counting the number of
apoptotic bodies identified within the crypts and villi.
The apoptotic index was defined as the ratio of apopto-
tic cells to the total number within the crypt-villus axis
per section. The mean value of 4 sections was calcu-
lated per sample.
Nutrition and Biochemical Parameters
Serum biochemical parameters, including total pro-
tein, albumin, gamma glutamyltransferase (GGT), and
total bilirubin, were measured. Serum was drawn via
inferior vena caval puncture immediately after killing.
Tests were performed by the clinical laboratory in our
hospital using standardized methods.
Data Analysis
Statistical analysis was carried out using the t-test
for comparison of 2 means and a one-way ANOVA for
comparison of multiple groups (with a Bonferroni post
hoc analysis to assess statistical differences between
groups). The 2 test was used for categorical data.
Linear regression analysis was used to correlate the
amount of energy delivered via PN to the several
observed outcome changes, including survival and
intestinal morphology. Prism software was used
(GraphPad Software, Inc, San Diego, CA). Statistical
significance was defined as p  .05. All data are
expressed as means  SD.
RESULTS
General Outcome
Survival progressively worsened in the PN mice as
the rate of infusion increased (36%, 40%, and 58% for
the Very Low, Reduced and Full PN groups) compared
with 100% survival in the enteral control group. No
correlation could be made, however, between the
amount of energy delivery and survival (p  .05). The
cause of death was consistently due to accumulation of
a leakage of PN fluid in the neck of mice in the Full
energy delivery group and due to a number of factors
for mice in the lower rates, including PN extravasa-
tion, apparent sepsis, or line occlusion.
Initial body weight of mice did not differ between PN
and control groups (p  .05). After 7 days of PN, body
weight in all 3 PN groups was significantly lower com-
pared with controls (p  .01; Figure 1). Weight loss (%
of initial weight) was greatest in the Very Low PN
group, reaching 25.3%  7.2%, and was progressively
less for the Reduced (10.35%  5.2%) and Full PN
(12.63%  6.4%) groups; compared with them, only
0.24%  4.26% for control group. Weight losses
between PN groups, however, were not significantly
different (p  .05).
Intestinal Morphology
Villus lengths and crypt depths in the 3 PN groups
were significantly lower compared with the control
group (p  .01). In addition, villus length and crypt
depth showed the greatest degree of atrophy in the
Very Low PN group vs Reduced and Full groups (p 
.05, Table III). Thus, progressively lower amounts of
caloric delivery resulted in progressively greater
degrees of mucosal atrophy (Figure 2); however, linear
FIGURE 1. Body weight in all PN groups was significantly less com-
pared with control after 7 days of infusion (p  .01). Body weight loss
was greatest in the Very Low group. (Percentage weight loss calcu-
lated as: [Initial weight  Final weight]/[Initial weight]  100).
TABLE III




Full PN 320.9  63.6*† 82.6  14.9*†
Reduced PN 308.4  65.2* 76.1  7.4*†
Very Low PN 259.5  58.3* 56.6  8.9*
Control 397.4  49.5 121.4  27.2
*Compared with control group: p  .01. †Compared with the Very
Low PN group: p  .05.
476 SUN ET AL Vol. 30, No. 6
regression analysis did not demonstrate a statistically
significant relation between the level of energy deliv-
ered and the degree of intestinal atrophy (p  .05).
Intestinal EC Apoptosis
The apoptotic index was significantly higher in all
PN groups by 2-fold, in comparison to controls, both
in the villi and in the crypts (p  .01). A consistent
trend toward increasing apoptotic index was found
with decreasing caloric intake, although the difference
in apoptotic index between PN groups did not reach
significance by ANOVA (p  .05, Table IV).
Biochemistry
After 7 days of PN, serum biochemical and nutrition
parameters were similar to baseline (control) values
(Table V), with the notable exception of alanine ami-
notransferase, which was markedly elevated in the
Very Low group. Total bilirubin and GGT were ele-
vated in the Full PN group, possibly suggestive of a
cholestatic process. Other values (serum albumin and
total protein) were not markedly affected by 7 days of
PN either at Full, Reduced, or Very Low rates of caloric
delivery. Blood glucose levels were somewhat elevated
in all groups at the onset of the experimental week,
including the control population, potentially due to the
stress of the operative procedure (185, 224, 146, and
221 mg/Dl for Enteral control, Very Low, Reduced and
Full PN groups, respectively, mean value from 3 mice).
Levels decreased toward the latter half of the ex-
periment, and none of the PN groups were felt to be
excessively elevated (190, 140, 89, and 156 mg/dL for
Enteral control, Very Low, Reduced, and Full PN
groups, respectively; mean value from 3 mice).
Bacterial Translocation
Bacterial translocation results are shown in Table
VI. In the PN groups, the percentage of bacterial trans-
location to mesenteric lymph nodes, liver, and spleen in
Very Low, Reduced, and Full groups was 38.1%, 55.6%,
and 33.3% for Gram-negative cultures and 52.4%,
55.6%, and 53.3% for Gram-positive cultures, respec-
tively. In contrast, the control group demonstrated
bacterial translocation in only 11.1% of Gram-positive
and 0% of Gram-negative cultures (p  .01 vs all PN
groups). No significance in bacterial translocation
rates was found between PN groups.
TABLE IV
Intestinal epithelial cell apoptosis
Very Low Reduced Full Control
Apoptotic index/villus 0.16  0.03* 0.17  0.04* 0.14  0.03* 0.06  0.01
Apoptotic index/crypts 0.114  0.03* 0.111  0.02* 0.089  0.03* 0.041  0.01
Compared with control group: *p  .01.
FIGURE 2. Progressively lower amounts of caloric delivery resulted in progressively greater degrees of mucosal atrophy. A, Very Low PN
intestine villus; B, Reduced PN; C, Full PN; and D, Enteral control. Photomicrographs are taken at 40 magnification.
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DISCUSSION
This study has compared the effect of different levels
of nutrition delivery on known PN-associated patho-
logic changes. Although PN is known to induce villus
and crypt atrophy, epithelial apoptosis, and bacterial
translocation in the mouse PN model, the effect of
reducing nutrition delivery on these changes has not
previously been well characterized. Our data indicate
that although PN-associated epithelial derangements
are significantly worsened by reducing the caloric PN
delivery, even with full caloric delivery (100% of nor-
mal for the mouse), mucosal morphology and function
are still significantly compromised in comparison to
the control state (enteral nutrition). It is possible that
the differences in this morphology may also be due to
some differences in protein and fat delivery to PN mice
compared with the enteral group. Even in the
PN group receiving equivalent calories to the control
group, fat delivery was slightly higher and protein
delivery was lower (see Table I). These differences may
account for some of these changes, although it was felt
that the greatest difference was predominantly in the
caloric delivery between the groups. Thus, PN-associ-
ated changes may be worsened by a reduction in caloric
delivery but are not completely reversed by full caloric
delivery in the absence of enteral nutrition. These find-
ings are consistent with another study indicating that
the absence of enteral nutrition, and not PN per se, is
the most important reason for PN-associated intestinal
pathology.6 The current study, however, demonstrates
a significant correlation between the degree of these
adaptive changes and the amount of calories delivered
via PN.
The significance of PN-associated villus atrophy has
been debated. Villus atrophy may contribute to greater
epithelial permeability and loss of barrier function,
which may lead to bacterial translocation and subse-
quent sepsis.14,15 The etiology of PN-associated villus
atrophy is unknown, although numerous mechanisms
responsible for this loss of villus length have been
proposed.16,17 Intestinal EC apoptosis is clearly ele-
vated with PN.2 It was also verified in this study that
the apoptotic index was significantly higher in all PN
groups by 2-fold, in comparison to controls, both in
the villi and in the crypts. A consistent trend toward
increasing apoptotic index was found with decreasing
caloric intake. In addition, a loss of hormonal stimu-
lation and of nutrition substrates may contribute to
villus atrophy.17–19 Several components of enteral
nutrition, including dietary fiber and protein, have pro-
tective effects on the intestinal mucosa.17–20 Further-
more, even when animals undergo minimal stress and
gain sufficient body weight with PN, the absence of
enteral nutrients results in a decrease in intestinal
function and integrity.20
Biochemical aberrations included an increase in
GGT and total bilirubin in the Full PN group and an
increased alanine aminotransferase (ALT) in the Low
PN group. Although the etiology of PN-related cho-
lestasis is unknown, these laboratory changes suggest
that PN may adversely affect the liver in different
fashions, depending on the amount of delivered nutri-
ents. Interestingly, the incidence of bacterial translo-
cation was unaffected by the level of caloric PN deliv-
ery. In all PN groups, bacterial translocation was
dramatically higher than in mice receiving enteral
nutrition. The explanation for PN-associated bacterial
translocation is incompletely understood, although it is
clear that intraepithelial lymphocytes (IEL; closely asso-
ciated with the intestinal epithelium) undergo pheno-
typic and function changes with PN administration, with
a loss of thymic-derived CD8	
 lymphocytes,7 an up-
regulation of IEL-derived IFN- expression,2 a decreased
mucosal IgA level, and diminished T-cell and B-cell
counts in Peyer’s patches.21 Thus, either epithelial apo-
ptosis and increased permeability or associated mucosal
immune changes may account for the observed elevation
in bacterial translocation.
TABLE V










Very Low, n  7 5.6 2.7 177 17 1.7
Reduced, n  6 5.6 2.5 62 7 1.5
Full, n  5 6.3 4.3 56 51 2.7
Control, n  6 5.6 2.7 44 10.3 1.6
Levels were analyzed using an Ektachem 750 system (Johnson & Johnson Inc, New Brunswick, NJ).




MacConkey agar (Gram-negative) CAN (Gram-positive)
Positive Negative % Positive Positive Negative % Positive
Very Low, n  7 8* 13 38.1 11* 10 52.4
Reduced, n  6 10* 8 55.6 10* 8 55.6
Full, n  5 5* 10 33.3 8* 7 53.3
Control, n  6 0 18 0 2 16 11.1
Compared with control group: *p  .01. No significance in bacterial translocation rates was found between PN groups.
CAN, colistin nalidixic acid media.
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The current data show a clear correlation between
level of caloric delivery and epithelial apoptosis. This
suggests involvement of the starvation response in
induction of intestinal epithelial apoptosis, although it
is equally clear that absence of enteral nutrients serves
as another key trigger for EC apoptosis, even when
sufficient parenteral nutrients are provided. Local and
systemic signals triggering intestinal EC apoptosis
include interferon- and other cytokines elaborated by
IEL, but control of EC apoptosis is not yet completely
understood.2,3
The mouse PN model has been extensively used and
is a key model for molecular studies in PN. As IV
infusion studies are becoming increasingly common in
mouse models, technical aspects of these models are of
paramount importance. We therefore recorded techni-
cal complications of this model, which have not been
described in detail previously. Increases in infusion
rates are achieved by incrementally increasing the
amount per bolus (and not by reducing the time inter-
val between boluses).22 Surprisingly, in our study,
higher infusion rates were associated with a very high
rate of technical failure (60%), usually attributable to
extravasation of PN at the cannulation site. Mice with
technical failure of IV infusion were not included in the
study. If infusion rates could be increased by reducing
the time interval between boluses (which is 20 seconds
on our pumps) rather than by increasing the size of the
individual bolus, we believe that this limitation in mice
could be overcome. From an experimental viewpoint,
the Reduced PN infusion group (0.3 mL/hour) appears
to be the most practical for further work, as it opti-
mized the balance between increased mortality associ-
ated with insufficient caloric intake vs technical fail-
ures (extravasation) associated with higher infusion
rates. An adjustment in the micro-infusion pumps
would probably resolve this difficulty. Although these
technical points are irrelevant to PN-induced epithelial
changes, we include this discussion because these
points have not been adequately reported previously.
These technical limitations should be considered by
any investigator planning infusion studies in mice.
In summary, PN induces significant derangements
in intestinal EC physiology, including higher apoptotic
rates, villus atrophy, and greater degrees of mucosal
permeability. The current study has shown that al-
though a strong correlation exists between the level of
caloric delivery and the severity of many of these
derangements, the level of caloric delivery does not
entirely account for these changes. To a substantial
degree, villus atrophy, apoptosis, and mucosal perme-
ability can only be corrected by provision of intralumi-
nal nutrition.
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